SRRK Scholar Rock Holding Corp

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia.

$29.87  -1.93 (-6.07%)
As of 04/09/2021 15:59:43 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/24/2018
Outstanding shares:  34,262,713
Average volume:  454,824
Market cap:   $1,025,825,627
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    80706P103
ISIN:        US80706P1030
Sedol:      BFZQ0L8
Valuation   (See tab for details)
PE ratio:   -11.86
PB ratio:   3.92
PS ratio:   66.60
Return on equity:   -33.16%
Net income %:   -561.47%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy